Test

Myeloproliferative Neoplasms (MPN)

• Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
• Chronic Neutrophilic Leukemia (CNL)
• Polycythemia Vera (PV)
• Primary Myelofibrosis (PMF)
• Essential Thrombocythemia (ET)
• Chronic Eosinophilic Leukemia, Not Otherwise Specified
• Myeloproliferative Neoplasm (MPN), Unclassifiable

Mastocytosis

• Cutaneous Mastocytosis
• Systemic Mastocytosis
• Mast Cell Sarcoma

Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2

• Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement
• Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement
• Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
• Myeloid/Lymphoid Neoplasms with PCM1-JAK2

Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

• Chronic Myelomonocytic Leukemia (CMML)
• Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative
• Juvenile Myelomonocytic Leukemia (JMML)
• MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)
• MDS/MPN, Unclassifiable

Myelodysplastic Syndromes (MDS)

• MDS with Single Lineage Dysplasia
• MDS with Ring Sideroblasts (MDS-RS)
• MDS with Ring Sideroblasts and Multilineage Dysplasia
• MDS with Multilineage Dysplasia
• MDS with Excess Blasts
• MSD with Isolated del(5q)
• MDS, Unclassifiable
• Refractory Cytopenia of Childhood

Myeloid Neoplasms with Germline Predisposition

• Acute Myeloid Leukaemia with Germline CEBPA Mutation
• Myeloid Neoplasms with Germline DDX41 Mutation
• Myeloid Neoplasms with Germline RUNX1 Mutation
• Myeloid Neoplasms with Germline ANKRD26 Mutation
• Myeloid Neoplasms with Germline ETV6 Mutation
• Myeloid Neoplasms with Germline GATA2 Mutation

Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms

• AML with Recurrent Genetic Abnormalities

  - AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
  - AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
  - Acute Promyelocytic Leukemia (APL) with PML-RARA
  - AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3
  - AML with t(6;9)(p23;q34.1); DEK-NUP214
  - AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM
  - AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1
  - AML with BCR-ABL1
  - AML with Mutated NPM1
  - AML with Biallelic Mutations of CEBPA
  - AML with Mutated RUNX1

• AML with Myelodysplasia-Related Changes

• Therapy-Related Myeloid Neoplasms

• AML, Not Otherwise Specified

  - AML with Minimal Differentiation
  - AML without Maturation
  - AML with Maturation
  - Acute Myelomonocytic Leukemia
  - Acute Monoblastic and Monocytic Leukemia
  - Pure Erythroid Leukemia
  - Acute Megakaryoblastic Leukemia (AMKL)
  - Acute Basophilic Leukemia
  - Acute Panmyelosis with Myelofibrosis

• Myeloid Sarcoma

• Myeloid Proliferations Associated with Down Syndrome

  - Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome
  - Myeloid Leukemia Associated with Down Syndrome

Blastic Plasmacytoid Dendritic Cell Neoplasm

• Blastic Plasmacytoid Dendritic Cell Neoplasm

Acute Leukemias of Ambiguous Lineage

• Acute Leukemias of Ambiguous Lineage

  - Acute Undifferentiated Leukemia
  - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1
  - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged
  - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified
  - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified
  - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types
  - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)

Precursor Lymphoid Neoplasms (B-ALL, T-ALL)

• B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities

  - B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1
  - [[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged|]B-ALL with t(v;11q23.3)]
  - B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1
  - B-ALL with Hyperdiploidy
  - B-ALL with Hypodiploidy
  - B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3
  - B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1
  - B-ALL, BCR-ABL1-Like
  - B-ALL with iAMP21
  - B-ALL, Not Otherwise Specified

• T-Lymphoblastic Leukemia/Lymphoma (T-ALL)

  - Early T-Cell Precursor Lymphoblastic Leukemia
  - NK-Lymphoblastic Leukemia/Lymphoma

Mature B-Cell Neoplasms

• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  - Monoclonal B-cell Lymphocytosis

• B-cell Prolymphocytic Leukemia

• Splenic Marginal Zone Lymphoma

• Hairy Cell Leukemia

• Splenic B-cell Lymphoma/Leukemia, Unclassifiable

  - Splenic Diffuse Red Pulp Small B-cell Lymphoma
  - Hairy Cell Leukemia Variant

• Lymphoplasmacytic Lymphoma

  - Waldenstrom Macroglobulinemia

• IgM Monoclonal Gammopathy of Undetermined Significance

• Heavy Chain Diseases

  - Mu Heavy Chain Disease
  - Gamma Heavy Chain Disease
  - Alpha Heavy Chain Disease

• Plasma Cell Neoplasms

  - Non-IgM Monoclonal Gammopathy of Undetermined Significance
  - Plasma Cell Myeloma
  - Plasma Cell Myeloma Variants
  - Plasmacytoma
  - Monoclonal Immunoglobulin Deposition Diseases
        - Primary Amyloidosis
        - Light Chain and Heavy Chain Deposition Disease
  - Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome
        - POEMS Syndrome
        - TEMPI Syndrome

• Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)

• Nodal Marginal Zone Lymphoma

  - Paediatric Nodal Marginal Zone Lymphoma

• Follicular Lymphoma

  - Testicular Follicular Lymphoma
  - In Situ Follicular Neoplasia
  - Duodenal-Type Follicular Lymphoma

• Paediatric-Type Follicular Lymphoma

• Large B-cell Lymphoma with IRF4 Rearrangement

• Primary Cutaneous Follicle Centre Lymphoma

• Mantle Cell Lymphoma

  - Leukemic Non-Nodal Mantle Cell Lymphoma
  - In Situ Mantle Cell Neoplasia

• Diffuse Large B-cell Lymphoma, Not Otherwise Specified

• T-cell/Histiocyte-Rich Large B-cell Lymphoma

• Primary Diffuse Large B-cell Lymphoma of the CNS

• Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type

• EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)

• EBV-Positive Mucocutaneous Ulcer

• Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation

  - Fibrin-Associated Diffuse Large B-cell Lymphoma

• Lymphomatoid Granulomatosis

• Primary Mediastinal (Thymic) Large B-cell Lymphoma

• Intravascular Large B-cell Lymphoma

• ALK-Positive Large B-cell Lymphoma

• Plasmablastic Lymphoma

• Primary Effusion Lymphoma

• HHV8-Associated Lymphoproliferative Disorders

  - Multicentric Castleman Disease
  - HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)
  - HHV8-Positive Germinotropic Lymphoproliferative Disorder

• Burkitt Lymphoma

• Burkitt-Like Lymphoma with 11q Aberration

• High-Grade B-cell Lymphoma

  - High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
  - High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)

• B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma

Mature T- and NK-cell Neoplasms

• T-cell Prolymphocytic Leukemia

• T-cell Large Granular Lymphocytic Leukemia

• Chronic Lymphoproliferative Disorder of NK Cells

• Aggressive NK-cell Leukemia

• EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood

  - Systemic EBV-Positive T-cell Lymphoma of Childhood
  - Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form
  - Hydroa Vacciniforme-Like Lymphoproliferative Disorder
  - Severe Mosquito Bite Allergy

• Adult T-cell Leukemia/Lymphoma

• Extranodal NK/T-cell Lymphoma, Nasal Type

• Intestinal T-cell Lymphoma

  - Enteropathy-Associated T-cell Lymphoma
  - Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  - Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
  - Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract

• Hepatosplenic T-cell Lymphoma

• Subcutaneous Panniculitis-Like T-cell Lymphoma

• Mycosis Fungoides

• Sézary Syndrome

• Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders

  - Lymphomatoid Papulosis
  - Primary Cutaneous Anaplastic Large Cell Lymphoma

• Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes

  - Primary Cutaneous Gamma Delta T-cell Lymphoma
  - Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma
  - Primary Cutaneous Acral CD8+ T-cell Lymphoma
  - Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder

• Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)

• Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin

  - Angioimmunoblastic T-cell Lymphoma
  - Follicular T-cell Lymphoma
  - Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype

• Anaplastic Large Cell Lymphoma, ALK-Positive

• Anaplastic Large Cell Lymphoma, ALK-Negative

• Breast Implant-Associated Anaplastic Large Cell Lymphoma

Hodgkin Lymphomas

• Nodular Lymphocyte Predominant Hodgkin Lymphoma

• Classic Hodgkin Lymphoma

  - Nodular Sclerosis Classic Hodgkin Lymphoma
  - Lymphocyte-Rich Classic Hodgkin Lymphoma
  - Mixed Cellularity Classic Hodgkin Lymphoma
  - Lymphocyte-Depleted Classic Hodgkin Lymphoma

Immunodeficiency-Associated Lymphoproliferative Disorders

• Lymphomas Associated with HIV Infection

• Post-Transplant Lymphoproliferative Disorders

  - Non-Destructive Post-Transplant Lymphoproliferative Disorders
  - Polymorphic Post-Transplant Lymphoproliferative Disorders
  - Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)
        - Monomorphic B-cell PTLD
        - Monomorphic T/NK-cell PTLD
  - Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder

• Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders

Histiocytic and Dendritic Cell Neoplasms

• Histiocytic Sarcoma

• Tumors Derived From Langerhans Cells

  - Langerhans Cell Histiocytosis
  - Langerhans Cell Sarcoma

• Indeterminate Dendritic Cell Tumour

• Interdigitating Dendritic Cell Sarcoma

• Follicular Dendritic Cell Sarcoma

  - Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma

• Fibroblastic Reticular Cell Tumor

• Disseminated Juvenile Xanthogranuloma

• Erdheim-Chester Disease

Sort by date Sort by score

Enable comment auto-refresher

You are ignoring the author of this comment

Show comment | Manage ignore list

Dan

45 months ago

Score 0

just a test comment

Permalink | Reply

You are ignoring the author of this comment

Show comment | Manage ignore list

Dan

45 months ago

Score 0

just a reply

Permalink

Add your comment

Compendium of Cancer Genome Aberrations welcomes all comments. If you do not want to be anonymous, register or log in. It is free.